Sexually transmitted infection

Global Treatment and Diagnosis of Sexually Transmitted Diseases Market Report 2020 with Profiles of Abbott Laboratories, AbbVie, Novartis, Pfizer, and Thermo Fisher Scientific

Retrieved on: 
Wednesday, October 21, 2020
Articles, Medicine, Health, Disease transmission, Mycoplasma, RTT, Sexually transmitted infection, Disease, Antibiotic

DUBLIN, Oct. 21, 2020 /PRNewswire/ -- The "Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Oct. 21, 2020 /PRNewswire/ -- The "Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases" report has been added to ResearchAndMarkets.com's offering.
  • Market data in value terms is provided at global, regional, and country levels for disease areas and treatment by drug class.
  • Market data for sexually transmitted disease diagnostics is provided for regional levels, with details on test types.
  • It forecasts the global market by drug class for the treatment of STDs and discusses market data for antibiotics, antivirals/antiretrovirals, and other treatments.

Global Treatment and Diagnosis of Sexually Transmitted Diseases Markets, 2025 - Focus on Antibiotics, Antivirals/Antiretrovirals & EIA, ELISA, PCR, Rapid Diagnostics - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 15, 2020
Health, Infectious diseases, Articles, Medicine, Medical terminology, RTT, Actuarial science, Disease, Health, Sexually transmitted infection

The "Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases" report has been added to ResearchAndMarkets.com's offering.
  • Market data in value terms is provided at global, regional, and country levels for disease areas and treatment by drug class.
  • Market data for sexually transmitted disease diagnostics is provided for regional levels, with details on test types.
  • The regional overviews provide information on the epidemiology of sexually transmitted diseases by country and region and also details market data for each region.

Condom Market | Increasing Prevalence of STDs to Boost the Market Growth | Technavio

Retrieved on: 
Friday, October 9, 2020
Retail, Other Retail, RTT, Medical specialties, Sexually transmitted diseases and infections, Clinical medicine, Health, Prevention of HIV/AIDS, Infectious causes of cancer, Sexual health, Sexually transmitted infection, Condom, Female condom, Gonorrhea

The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Key Points: 
  • The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
  • View the full release here: https://www.businesswire.com/news/home/20201009005272/en/
    Technavio has announced its latest market research report titled Global Condom Market 2020-2024 (Graphic: Buiness Wire)
    The prevalence of sexually transmitted diseases such as syphilis, gonorrhea, chlamydia, hepatitis B, genital herpes, and HIV/AIDS is increasing.
  • To help clients improve their market position, this condom market forecast report provides a detailed analysis of the market leaders.
  • As the business impact of COVID-19 spreads, the global condom market 2020-2024 is expected to have Positive and Superior growth.

Chembio Diagnostics Receives FDA Approval for DPP HIV-Syphilis System

Retrieved on: 
Friday, October 2, 2020
Sexually transmitted diseases and infections, Medical specialties, Infectious diseases, Clinical medicine, Syphilis, Sexually transmitted infection, HIV

HAUPPAUGE, N.Y., Oct. 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the Premarket Approval (PMA) application for the DPP HIV-Syphilis System.

Key Points: 
  • HAUPPAUGE, N.Y., Oct. 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the Premarket Approval (PMA) application for the DPP HIV-Syphilis System.
  • The system includes the DPP HIV-Syphilis assay, a multiplex single-use test, and the DPP Micro Reader optical analyzer, and is being offered in the United States immediately.
  • The multiplex DPP HIV-Syphilis System represents a significant step forward in rapid testing for sexually transmitted diseases.
  • Chembios DPP HIV-Syphilis System assists clinicians in diagnosing HIV or syphilis while patients are still at a POC setting.

AHF Rings Alarm Over Nationwide Shortage of STD Test Kits

Retrieved on: 
Friday, September 25, 2020
AIDS, Health, Medical devices, Consumer, Infectious diseases, Hospitals, Gay & Lesbian, RTT, Sexually transmitted diseases and infections, Infectious causes of cancer, Chlamydiae, Mycoplasma, Sexually transmitted infection, Chlamydia, AIDS Healthcare Foundation, Clinical medicine, Gonorrhea, Health, Medical specialties

AIDS Healthcare Foundation ( AHF ) is raising alarm bells over an extreme nationwide shortage of test kits and laboratory supplies for sexually transmitted infections (STIs, often also referred to as sexually transmitted diseases or STDs), most notably, for chlamydia and gonorrhea nucleic amplification tests (CT/GC NAAT).

Key Points: 
  • AIDS Healthcare Foundation ( AHF ) is raising alarm bells over an extreme nationwide shortage of test kits and laboratory supplies for sexually transmitted infections (STIs, often also referred to as sexually transmitted diseases or STDs), most notably, for chlamydia and gonorrhea nucleic amplification tests (CT/GC NAAT).
  • The CDCs letter also offers Considerations for prioritizing STI testing if test kits are in short supply.
  • AHF, which operates 24 free STD testing and treatment centers, also known as AHF Wellness Centers , in nine states and Washington, D.C., has experienced the test kit shortages firsthand over the past two weeks.
  • The test kit shortage, due in part to supply chain interruptions caused by the pandemic, comes at a crucial and inopportune time.

Condom Market Size is Projected to Reach USD 13,405.31 Million by 2025 | Valuates Reports

Retrieved on: 
Thursday, September 24, 2020
RTT, Medical specialties, HIV/AIDS, Sexual health, Barrier contraception, Female condom, Vagina, Human reproduction, Condom, Sexually transmitted infection, Health, Condom effectiveness

The Global Condom Market size is expected to grow from USD 4,522.38 Million in 2019 to USD 13,405.31 Million by 2025 at a CAGR of 19.85%.

Key Points: 
  • The Global Condom Market size is expected to grow from USD 4,522.38 Million in 2019 to USD 13,405.31 Million by 2025 at a CAGR of 19.85%.
  • Major factors driving theCondom Market size are the growing understanding of sexually transmitted diseases (STDs) and HIV among adolescents.
  • The report provides a detailed evaluation of the Condom Market size by highlighting information on different aspects, which include drivers, limitations, opportunities, and threats.
  • The availability of a different variety of condoms around the world is fuelling the condom market size.

Condom Market Size is Projected to Reach USD 13,405.31 Million by 2025 | Valuates Reports

Retrieved on: 
Thursday, September 24, 2020
RTT, Medical specialties, HIV/AIDS, Sexual health, Barrier contraception, Female condom, Vagina, Human reproduction, Condom, Sexually transmitted infection, Health, Condom effectiveness

The Global Condom Market size is expected to grow from USD 4,522.38 Million in 2019 to USD 13,405.31 Million by 2025 at a CAGR of 19.85%.

Key Points: 
  • The Global Condom Market size is expected to grow from USD 4,522.38 Million in 2019 to USD 13,405.31 Million by 2025 at a CAGR of 19.85%.
  • Major factors driving theCondom Market size are the growing understanding of sexually transmitted diseases (STDs) and HIV among adolescents.
  • The report provides a detailed evaluation of the Condom Market size by highlighting information on different aspects, which include drivers, limitations, opportunities, and threats.
  • The availability of a different variety of condoms around the world is fuelling the condom market size.

STD Testing Market Size to Hit $133.93 Billion by 2025; Growing prevalence of STD, National Screening Programs have Fueled the Growth

Retrieved on: 
Thursday, September 3, 2020
RTT, Disease transmission, Mycoplasma, Sexually transmitted infection, Women's reproductive health in the United States

Growing prevalence of STD, implementation of national screening programs, and supporting reimbursement for STD testing have fueled the growth of the global STD testing market .

Key Points: 
  • Growing prevalence of STD, implementation of national screening programs, and supporting reimbursement for STD testing have fueled the growth of the global STD testing market .
  • Based on testing type, the laboratory testing segment generated the largest share in 2017, accounting for more than four-fifths of the total market.
  • Rise in incidence of sexually transmitted diseases across the region has spurred the growth of the market in the region.
  • Moreover, growing healthcare awareness and increase in responsiveness for early screening or diagnosis of the sexually transmitted diseases have accelerated the growth in more than one way.

MeetPositives.com Giving Herpes-Positive Individuals a Second Chance at Love

Retrieved on: 
Thursday, August 6, 2020
RTT, Medical specialties, Infectious diseases, Sexually transmitted diseases and infections, Virology, Viral diseases, Biology of bipolar disorder, Herpes simplex, Sexually transmitted infection, Draft:Meet Positives

"While those who are positive with herpes have done nothing wrong, many times they feel ashamed," states Jack Lombardi II, CEO ofMeetPositives.com.

Key Points: 
  • "While those who are positive with herpes have done nothing wrong, many times they feel ashamed," states Jack Lombardi II, CEO ofMeetPositives.com.
  • At the end of the day, we want our members to feel normal again they have already been through enough."
  • Because of this platform, individuals living with herpes no longer have to engage in difficult conversations with dating partners.
  • Created for STD-positive individuals, Meet Positives is an alternative to dating and a second chance for those living with a sexually transmitted disease.

Competing in the 2020 Global Sexually-Transmitted Disease (STD) Testing Market - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 27, 2020
Infectious diseases, Biotechnology, Pharmaceutical, Health, Cancer, RTT, Infectious causes of cancer, Health, Sexually transmitted diseases and infections, Medical specialties, Sexually transmitted infection, Human papillomavirus infection, Chlamydia, Pap test, Chancroid, Gonorrhea

The "Competing in the 2020 Global Sexually-Transmitted Disease (STD) Testing Market: Supplier Shares, Segment Forecasts for 8 Assays, Growth Opportunities for Suppliers" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Competing in the 2020 Global Sexually-Transmitted Disease (STD) Testing Market: Supplier Shares, Segment Forecasts for 8 Assays, Growth Opportunities for Suppliers" report has been added to ResearchAndMarkets.com's offering.
  • This report provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
  • The report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.
  • Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes, Papillomavirus, Pap Smear, HPV and Syphilis.